eisai's alzheimer's drug reduces cognitive decline by 27% in trial patients
Published 1 year ago • 2.9K plays • Length 3:58Download video MP4
Download video MP3
Similar videos
-
2:54
biogen and eisai to reveal results of alzheimer's drug trial
-
1:07
biogen and eisai report successful test on alzheimer's treatment
-
1:31
alzheimer's drug decision day: fda to decide on biogen and eisai treatments
-
3:54
eisai ceo on alzheimer's treatment drug trial results
-
5:57
cnbc exclusive: eisai u.s. ceo on alzheimer's drug approval
-
3:52
we believe the risk-benefit profile for our alzheimer's drug is acceptable, says eisai u.s. ceo
-
1:56
new alzheimer's drug shows promise in early results of study
-
5:25
experimental alzheimer's treatment slows cognitive decline, 'but it doesn't stop' the disease
-
1:10:00
market sell off wednesday july 24th
-
4:02
f-d-a approves new alzheimer's drug - kisunla
-
16:02
what’s the controversy behind biogen’s alzheimer’s drug?
-
4:03
eli lilly ceo: alzheimer's drug trial shows slowed disease progression by 40-60% in early patients
-
1:21
biogen shares drop despite positive alzheimer's drug results
-
1:41
alzheimer's drug slows decline but has side-effects
-
3:45
cramer: biogen's alzheimer's treatment would be 'the biggest drug ever'
-
2:19
tesla is the most undervalued ai play, ives says
-
3:47
this sell-off is just a market correction of the 'magnificent 7', says ed yardeni
-
1:01
alzheimer’s drug shows promise in early results of study
-
5:17
biogen ceo: alzheimer's drug shows positive results
-
5:19
analyst: it's unclear whether biogen's new alzheimer's drug will get approved
-
0:52
eisai applies for approval of new alzheimer's drug in japan
-
6:21
big win for biogen: alzheimer's drug results spark huge gains